Private equity: Biotechnology dilemmas and the “potential for harm”
Investment in biotech is booming. In Europe, the biotechnology and healthcare sector accounted for 20% of overall private equity investment...
Investment in biotech is booming. In Europe, the biotechnology and healthcare sector accounted for 20% of overall private equity investment...
The asset management industry’s role in the future of the planet has come into question again following the publication of...
During his time as president, Donald Trump shunned climate science and sustainability, backing coal and fossil fuels instead. Following Joe...
Last week saw unprecedented – although not entirely unexpected – scenes take place in Washington DC, as disenfranchised pro-Trump supporters...
After Joe Biden’s victory in the US presidential election, Alex Rolandi asks what impact the result could have on global...
European ETF issuers expect a surge in demand for thematic funds focusing on water, biotechnology, and technology, research shows. Cerulli...
Biotechnology – in the spotlight thanks to Covid-19 – surpasses even digital in terms of its scope to transform this...
Testing financial conditions during 2020 have added to the pressure on Australia’s superannuation industry to deliver better investment outcomes and...
© 2026 Funds Europe Limited, a wholly owned subsidiary of Definite Article Media Limited. Website design by Bedazzled Publishing Services Limited.
© 2026 Funds Europe Limited, a wholly owned subsidiary of Definite Article Media Limited. Website design by Bedazzled Publishing Services Limited.
© 2026 Funds Europe Limited, a wholly owned subsidiary of Definite Article Media Limited. Website design by Bedazzled Publishing Services Limited.
© 2026 Funds Europe Limited, a wholly owned subsidiary of Definite Article Media Limited. Website design by Bedazzled Publishing Services Limited.